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The actinomycete Rhodococcus equi is an important pathogen of horses and an emerging opportunistic
pathogen of humans. Identification of R. equi by classical bacteriological techniques is sometimes difficult, and
misclassification of an isolate is not uncommon. We report here on a specific PCR assay for the rapid and
reliable identification of R. equi. It is based on the amplification of a fragment of the choE gene encoding
cholesterol oxidase. The choE-based PCR was assessed by using a panel of strains comprising 132 isolates from
different sources and of different geographical origins, all initially identified biochemically as R. equi, and 30
isolates of representative non-R. equi actinomycete species, including cholesterol oxidase producers. The
expected 959-bp amplicon was observed only with R. equi isolates, as confirmed by sequencing of a variable
region of the 16S RNA gene from a random sample of 20 PCR-positive isolates. All R. equi isolates gave a
positive choE-based PCR result, which correlated with a high degree of conservation of the choE gene. Three
of the 132 strains originally identified as R. equi were negative for the choE gene, and subsequent analysis of
their 16S RNA gene sequences confirmed that they belonged to other bacterial species (Dietzia maris, Myco-
bacterium peregrinum, and Staphylococcus epidermidis). All non-R. equi isolates were negative by the choE-based
PCR. ATCC 21387, the only known isolate of Brevibacterium sterolicum, gave a 959-bp amplicon whose DNA
sequence was virtually identical to that of R. equi choE. Comparison of the 16S RNA genes indicated that ATCC
21387 should be considered an R. equi isolate.
The nocardioform actinomycete Rhodococcus equi is a pri-
mary pathogen of horses. In foals, R. equi causes severe pyo-
granulomatous pneumonia, often accompanied by ulcerative
enteritis and mesenteric lymphadenitis (29). In recent years, R.
equi has emerged as an important opportunistic pathogen in
humans, causing potentially life-threatening infections in se-
verely immunocompromised people, in particular, human im-
munodeficiency virus-infected patients (43). In humans, R. equi
causes a lung disease reminiscent of pulmonary tuberculosis. R.
equi can also infect cattle, in which it has been associated with
ulcerative lymphangitis (34), and it has also been recovered
from inflamed tonsils and the cervical lymph nodes of pigs (21,
34). The natural habitat of R. equi is the soil, especially that en-
riched with fecal material from domestic and wild animals (37).
R. equi infections are diagnosed by culturing and subsequent
phenotypic analysis of the isolates by means of classical mor-
phological and biochemical tests (9). However, the colony
characteristics, cellular morphology, and reaction to acid-fast
staining differ between R. equi isolates (32). Although the API
Coryne multisubstrate identification system (bio-Merieux), a
commercial kit widely used in clinical microbiology laborato-
ries, includes R. equi in its database, its reliability for the
biochemical identification of rhodococcal isolates is limited (8,
35). These inconsistent test results for R. equi frequently result
in misidentification, in which R. equi is mistaken as other rho-
dococcal species or even corynebacteria or other actinomyce-
tes (10, 16, 36). Accurate identification of Rhodococcus isolates
to the species level is possible on the basis of chemotaxonomic
properties (11). However, these techniques are excessively la-
borious, time-consuming, and expensive for routine use in clin-
ical microbiology laboratories.
We recently identified the R. equi choE gene, a chromo-
somal locus encoding cholesterol oxidase (22), an enzyme be-
lieved to be a major virulence factor of R. equi (13). Mutational
analysis indicated that ChoE is the membrane-damaging factor
responsible for the typically shovel-shaped synergistic hemoly-
sis (CAMP-like) reaction elicited by R. equi in the presence
of sphingomyelinase C-producing bacteria, such as Listeria
ivanovii, Bacillus cereus, and Staphylococcus aureus (22). This
CAMP-like reaction can be used as a phenotypic marker for
the rapid presumptive identification of R. equi (30; unpub-
lished data). We describe here a new PCR method for the
rapid and specific identification of R. equi based on the detec-
tion of choE sequences. This assay accurately differentiated
R. equi from other closely related actinomycetes and correctly
reassigned strains initially incorrectly identified as R. equi to
other species on the basis of morphological and biochemical
characteristics. It also identified as R. equi a well-known cho-
lesterol oxidase-producing strain, Brevibacterium sterolicum
ATCC 21387 (7).
* Corresponding author. Mailing address: Facultad de Medicina,
Departamento de Biología Molecular, Universidad de Cantabria, Her-
rera Oria s/n, 39011 Santander, Spain. Phone: 34 942 201 943. Fax: 34
942 201 945. E-mail: navasj@correo.unican.es.
3241
 o
n
 February 18, 2014 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
MATERIALS AND METHODS
Bacterial strains and microbiological procedures. A total of 132 isolates from
different geographical areas (Spain, France, Germany, the Dominican Republic,
and Australia), identified at the source as R. equi, were included in the study. The
132 strains comprised 34 strains from pneumonic foals, 49 strains from human
AIDS patients, and 49 strains from nonclinical samples (46 strains from soil and
3 strains from foal feces). Three R. equi reference strains, strains 103 (5), ATCC
6939 (the type strain of R. equi, also known as the Magnusson strain [18]), and
ATCC 33701 (28), as well as 30 isolates of representative actinomycetes, were
included as controls (Table 1). The bacteria were routinely cultured at 37°C for
48 h by using brain heart infusion as the base medium. Viable counts were
determined by plating 10-fold serial dilutions of the initial bacterial suspension.
CAMP-like synergistic hemolysis tests were performed on sheep blood agar
plates with Columbia base medium (bioMe´rieux) and L. ivanovii ATCC 19119 as
the indicator strain, as described previously (22, 30).
General DNA procedures. Bacterial genomic DNA was routinely prepared by
suspending one colony in 50 l of distilled water; the same volume of Instagene
matrix (Bio-Rad) was added, and the mixture was heated at 80°C for 10 min. The
samples were centrifuged at 10,000  g for 5 min, and the supernatants were
used for PCR amplification. Bacterial dilutions used in PCR sensitivity tests were
processed in the same way. Highly purified, concentrated genomic DNA for use
in sensitivity tests was obtained as described previously (22). DNA concentra-
tions were determined both by agarose gel electrophoresis and spectrophoto-
metrically. Both strands of the PCR products were sequenced with an Applied
Biosystems 377 apparatus. The sequences were analyzed by using the BLAST (1)
network service from the National Center for Biotechnology Information (Be-
thesda, Md.) and were aligned by use of the AlignX program (InforMax, Be-
thesda, Md.). For restriction fragment length polymorphism (RFLP) analysis,
the choE amplicons were purified by use of the Gel Extraction Purification kit
(Qiagen) and were subsequently digested with the following restriction enzymes:
AvaI, BamHI, BglI, HinPI, PvuI, XhoI, and XmnI (New England Biolabs, Bev-
erly, Mass.). The digestion products were resolved by electrophoresis on 1.2%
agarose gels in Tris borate buffer and were visualized by ethidium bromide
staining.
Primers and PCR conditions. The oligonucleotide primers were synthesized
by TIB MOLBIOL (Berlin, Germany). The reaction mixture for PCR amplifi-
cation consisted of 10 l of DNA template, 4 U of Taq DNA polymerase
(Bioline, London, United Kingdom), 1.5 mM MgCl2, 10 l of 10 PCR ampli-
fication buffer [160 mM (NH4)2SO4, 670 mM Tris-HCl (pH 8.8), 0.1% Tween
20], 40 pmol of each primer, 0.2 mM each deoxynucleoside triphosphate (Bio-
line), and double-distilled water to a final volume of 100 l. The DNA was first
denatured at 95°C for 5 min and was then subjected to 30 amplification cycles
under the following conditions: denaturation at 95°C for 1 min, annealing at 55°C
for 1 min, and extension at 72°C for 1 min. After the final cycle, the reactions
were terminated by an extra run at 72°C for 10 min, and then the mixtures were
kept at 4°C until they were analyzed.
All strains tested in this study were amplified at least three times.
Nucleotide sequence accession numbers. The 16S rRNA gene (rDNA) se-
quences from strains 20 and 21 are registered in the GenBank database under
accession numbers AF537361 and AF537362, respectively.
RESULTS
R. equi-specific PCR based on choE. Oligonucleotide prim-
ers were designed after alignment of the sequence of choE
from R. equi strain 103, recently determined in our laboratory
(22), with other known or putative cholesterol oxidase gene
sequences available in databases (Mycobacterium tuberculosis,
GenBank accession no. X99343; Mycobacterium leprae, Gen-
Bank accession no. NC002677; Streptomyces coelicolor, GenBank
accession no. AL161755; Streptomyces sp. choA, GenBank ac-
cession no. M31939; Streptomyces sp. choM, GenBank acces-
sion no. U13981; Pimelobacter simplex, GenBank accession no.
AF247810; and Burkholderia cepacia, GenBank accession no.
AB051407) to identify areas of similarity and difference. On
the basis of that analysis we defined the 21-mer R. equi-spe-
cific primers COX-F (5-GTCAACAACATCGACCAGGCG),
corresponding to positions 1221 to 1241 (forward primer),
and COX-R (5-CGAGCCGTCCACGACGTACAG), com-
plementary to the sequence spanning positions 2160 to 2180
(reverse primer) (coordinates are according to the sequence of
the choE region deposited in the EMBL data bank under
accession no. AJ242746). These primers are predicted to give
an amplicon of 959 bp, according to the sequence of R. equi
strain 103.
Genomic DNA from R. equi reference strains 103, ATCC
6939, and ATCC 33701 and from 132 isolates from different
sources and of different geographical origins presumptively
identified as R. equi were screened by PCR with the COX
primers described above. For the 3 reference strains and for
129 of the presumptive R. equi isolates, the PCR resulted in the
production of the expected 0.95-kbp product (Fig. 1). A region
of the 16S rDNA comprising species-specific sequences was
amplified by PCR with primers DG74 and PL06 (12) from a
random sample of 20 of the choE-based PCR (choE PCR)-
positive isolates and sequenced. These 20 strains included both
TABLE 1. Non-R. equi strains used in the study
Species Strain
Corynebacterium sp. ...........................................................ATCCa 14665
Corynebacterium kutscheri .................................................ATCC 15677
Corynebacterium variabilis .................................................ATCC 33010
Corynebacterium xerosis .....................................................NCIMBb 9956
Corynebacterium pseudotuberculosis .................................ATCC 19410
Corynebacterium bovis........................................................CAc 23
Corynebacterium aquaticum...............................................CA 29
Corynebacterium urealyticum .............................................ATCC 43042
Mycobacterium sp. ..............................................................NCIMB 11678
Mycobacterium phlei ...........................................................ATCC 11758
Mycobacterium smegmatis..................................................ATCC 14468
Mycobacterium bovis BCG ................................................ATCC 35744
Mycobacterium xenopi ........................................................CA 78931
Mycobacterium kansasii......................................................CA 70243
Mycobacterium tuberculosis ...............................................CA 1908
Mycobacterium terrae..........................................................CA 52828
Mycobacterium chelonae ....................................................CA 71765
Mycobacterium lentiflavum ................................................CA 33805
Brevibacterium sp................................................................CA 157
Brevibacterium sterolicum ..................................................ATCC 21387
Nocardia sp. ........................................................................CA 158
Nocardia asteroides .............................................................ATCC 14759
Rhodococcus sp. .................................................................NCIMB 9457
Rhodococcus erythropolis ...................................................ATCC 11048
Gordonia sp.........................................................................CA 93049
Gordonia bronchialis ..........................................................ATCC 25592
Tsukamurella pulmonis ......................................................CIPd 104791T
Dietzia maris........................................................................ATCC 35013T
Turicella otitidis...................................................................CA 62716
Streptomyces sp. ..................................................................CA 163
a ATCC, American Type Culture Collection.
b NCIMB, National Collections of Industrial and Marine Bacteria.
c CA, Collection of Actinomycetes of the Department of Biochemistry and
Molecular Biology of the University of Cantabria. All strains were originally
isolated from animal samples in the Animal Health Regional Laboratory, or
from human patients in the Marque´s de Valdecilla Hospital, Cantabria, Spain.
They were identified by phenotypic analysis and 16S rDNA sequencing.
d CIP, Collection of Institut Pasteur, Paris, France.
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human and animal clinical isolates and environmental isolates.
Their sequences were compared to the 16S rRNA sequences in
databases, which confirmed that all the isolates belonged to R.
equi. Only 3 of the 132 isolates (isolates 11, 20, and 21) gave a
negative choE PCR result. The complete sequence of the 16S
rDNA of each of these negative strains was determined after
PCR amplification with primers 16S-F (5-AGAGTTTGATC
CTGGCTCAG) and 16S-R (5-AGGAGGTGATCCAGCC
GC). Strain 11 was identified as S. epidermidis (99% identity
with S. epidermidis ATCC 14990T 16S rDNA), strain 20 was
identified as D. maris (99% identity with D. maris ATCC
35013T), and strain 21 was identified as M. peregrinum (98%
identity with M. peregrinum ATCC 14467).
The specificity of the choE PCR was verified by testing 30
strains from representative actinomycete species (Table 1).
These strains included bacteria known to express cholesterol
oxidase activity or to encode putative cholesterol oxidase en-
zymes, such as Brevibacterium spp., Mycobacterium spp., No-
cardia asteroides, Rhodococcus erythropolis, and Streptomyces
spp. (17). No amplification product was detected for any of
these strains except one, Brevibacterium sterolicum ATCC 21387,
for which a 0.95-kbp product, i.e., a product of the same size as
that obtained with the R. equi isolates, was observed (Fig. 1). A
further detailed analysis of the B. sterolicum strain indicated
that it was missclassified and belonged to the R. equi taxon (see
below).
In vitro sensitivity of choE PCR for R. equi. The in vitro
sensitivity of the PCR test was assessed by determining both
the minimum amount of DNA and the minimum number of
bacterial cells required for detection of a 959-bp choE ampli-
con. For these tests, 10-fold dilutions of highly purified DNA
or an exponential-phase culture (optical density at 600 nm 
0.5) of R. equi reference strains ATCC 6939 and ATCC 33701
were used. A positive result was obtained with a minimum of
0.02 ng of DNA or 3 R. equi CFU (Fig. 2).
Conservation of choE sequences in R. equi. The choE gene of
strain 103 maps to a 2.3-kbp PstI chromosomal fragment (22).
Southern blot analyses revealed this same hybridization pat-
tern in type strain ATCC 6939 and in the 20 choE PCR-
positive isolates used for the 16S rDNA cataloguing described
above (data not shown), suggesting a high degree of conserva-
tion of the choE sequence in R. equi. We confirmed this by
DNA sequencing and RFLP analysis. The complete sequences
of the choE genes from 3 of the 20 R. equi strains, selected on
the basis of their different degrees of cholesterol oxidase and
cognate CAMP-like activities (strain 2, isolated from a dis-
eased foal, had a high level of activity; strain 3, from a human
patient, had an intermediate level of activity; and strain 70, also
from a human patient, was exceptional, in that it presented no
detectable activity), were determined. These three choE se-
quences diverged only minimally (sequence identities, 99.5%).
RFLP analyses of the 959-bp choE amplicons from the 20
R. equi isolates previously analyzed by Southern blotting also
revealed identical patterns for each of the seven restriction
enzymes used (Fig. 3).
Reclassification of B. sterolicum ATCC 21387 as R. equi.
Comparison of the cholesterol oxidase gene sequences of
R. equi 103 (choE) and B. sterolicum ATCC 21387 (choB) (22)
revealed they were almost identical, consistent with the posi-
tive result obtained with B. sterolicum ATCC 21387 by PCR
with the COX primers (see above). This high degree of se-
quence conservation between choE and choB derived from two
presumptively different bacterial species was surprising in view
of the substantial degree of divergence (81%) that exists be-
tween cholesterol oxidase genes from different actinomycetes,
even for those belonging to the same genus (as, for example,
the case of Streptomyces sp. choA and choM alleles, which are
only 86% identical). Given the strong sequence conservation of
choE among R. equi isolates, the identity between choE and the
reported choB sequence could be explained either (i) by a re-
cent horizontal gene transfer event between R. equi and B. ste-
rolicum or (ii) by the fact that ATCC 21387 is an R. equi isolate.
FIG. 1. Representative choE PCR amplification products obtained
from genomic DNA samples of R. equi. Lanes: 1, strain 103; 2, ATCC
6939; 3, isolate 70; 4, isolate 11; 5, isolate 20; 6, isolate 21; 7, B. stero-
licum ATCC 21387; M, DNA size marker.
FIG. 2. Sensitivity of the choE PCR. (A) choE amplicon obtained
with various amounts of purified R. equi ATCC 6939 genomic DNA.
Lane M, DNA size marker; lanes 1 to 6, serial 10-fold dilutions of the
DNA preparation (lane 1, 200 ng; lane 6, 2 pg). (B) choE amplicons
obtained with various quantities of R. equi ATCC 6939 bacterial cells.
Lane M, DNA size marker; lanes 1 to 5, 3  104, 3  103, 3  102, 30,
and 3 CFU, respectively.
FIG. 3. RFLP patterns of choE amplicons from three R. equi iso-
lates (strains 15, 65, and 115, of equine, human, and environmental
origin, respectively, in that order for the digestions with each of the
enzymes) digested with PvuI (lanes 1 to 3), XhoI (lanes 4 to 6), XmnI
(lanes 7 to 9), AvaI (lanes 10 to 12), BamHI (lanes 13 to 15), BglI
(lanes 16 to 18), and HinPI (lanes 19 to 21). Lane M, DNA size
marker.
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To discriminate between these two possibilities, we determined
the complete sequence of the 16S rDNA of ATCC 21387 after
PCR amplification with primers 16S-F and 16S-R (see above).
The sequence was 100% identical to that of R. equi type strain
ATCC 6939 (GenBank accession no. X80603), indicating that
B. sterolicum ATCC 21387 is in fact an R. equi strain. ATCC
21387 gives a CAMP-like reaction with L. ivanovii. Further-
more, the biochemical profiles of ATCC 21387 determined
with the API Coryne system are fully compatible with those of
R. equi and less similar to those of Brevibacterium.
DISCUSSION
In this work, we studied the usefulness of the R. equi cho-
lesterol oxidase gene, choE, recently identified and character-
ized in our laboratory (22), as a target for the development of
a species-specific PCR method for the rapid identification of
this pathogenic nocardioform actinomycete. Routine applica-
tion of a PCR-based method requires that the target sequence
be highly specific for the microorganism and that it be highly
conserved in all strains of that organism. Our results show that
the choE target sequence used fulfills these requirements. Se-
quences complementary to the COX primers were present in
all of the isolates included in a large collection of R. equi strains
from different sources and of different geographical origins,
suggesting that they are universally conserved in this bacterial
species. This is consistent with the production of extracellular
choE-derived cholesterol oxidase activity and of its associated
phenotypic marker, the CAMP-like reaction with L. ivanovii,
by virtually all isolates of R. equi (unpublished data). On the
other hand, no choE amplicon was detected in any of the 29
actinomycetes used as negative controls, which included rele-
vant pathogenic species, such as N. asteroides and M. tubercu-
losis, that also produce cholesterol oxidase activity or that carry
choE-related genes (17). Most importantly, these negative con-
trol strains included cholesterol oxidase-producing rhodococci,
demonstrating the species specificity of our PCR method. The
choE gene homologs carried by these bacteria were sufficiently
divergent to prevent positive amplification with our COX
primers. The specificities of these primers for R. equi were
corroborated by sequence analysis of the 16S rDNA from a
representative sample of the choE PCR-positive strains.
Interestingly, one R. equi isolate from the panel of isolates
tested did not produce detectable CAMP-like activity but gave
a positive choE PCR result. This illustrates the validity of the
molecular method that we developed as a tool to identify R.
equi, as it gives positive results even for rhodococcal strains
that do not express the choE-associated phenotypic marker.
The cholesterol oxidase-nonproducing R. equi isolate, strain
70, acquired the capacity to produce an active enzyme (and
CAMP-like reactivity) upon complementation with a plasmid
carrying a wild-type choE gene, indicating that that strain bears
a nonfunctional choE allele. Analysis of the strain 70 choE
sequence revealed the presence of a 1-bp insertion in the 5
region of the gene that produced a frame shift and, subse-
quently, the loss of cholesterol oxidase activity (unpublished
results).
The choE PCR with the COX primers also identified three
isolates that had incorrectly been identified as R. equi accord-
ing to the negative PCR results, thus further illustrating the
value of the assay. These three isolates were confirmed to be
non-R. equi isolates by 16S rDNA sequencing. One, an isolate
from the bone marrow of a human patient with human immu-
nodeficiency virus infection, was identified as D. maris, a halo-
philic actinomycete previously reported as being involved in
human infections only on two occasions (4, 27). The second
isolate was identified as M. peregrinum, a species also rarely
found as a cause of opportunistic infections in humans (25, 31).
The third was a strain of S. epidermidis, a coagulase-negative
Staphylococcus sp., which was possibly identified as R. equi on
the basis of positivity by Gram staining, the coccoid aspect
often presented by R. equi, and the resemblance of old R. equi
colonies to those of staphylococci.
B. sterolicum ATCC 21387 was the only presumptive non-
R. equi strain included in our study which yielded a 0.95-kb
PCR product with the COX primers. ATCC 21387 is a well-
known strain used for the industrial production of cholesterol
oxidase and the extensive genetic and biochemical character-
ization of this enzyme (20, 23, 24). Indeed, the three-dimen-
sional crystal structure of the cholesterol oxidase protein was
determined by using the purified enzyme from B. sterolicum
ATCC 21387 (15). Our previous data showed that the se-
quence of the cholesterol oxidase gene from B. sterolicum
ATCC 21387, designated choB, was almost identical to that of
choE from R. equi (22). Here we found that the 16S rDNA
sequence of ATCC 21387 is also identical to that of R. equi.
This finding, together with the strong conservation of the choE
gene sequence among R. equi isolates, indicates that ATCC
21387, the only known strain of the species “B. sterolicum,” was
misclassified and is R. equi.
Only a few rapid molecular methods have been developed
for R. equi identification. Clinical isolates from foals can be
identified by detection of the VapA antigen, with monoclonal
antibodies, or alternatively, by PCR detection of its gene, vapA,
which is present on an 85-kb virulence plasmid (38, 39, 40).
However, the virulence plasmid is not present in all strains of
human and environmental origin (in general, in nonequine
isolates) (41), thus limiting the general usefulness of the vapA-
based identification of R. equi by PCR. Other PCR-based mo-
lecular methods have been used to amplify a chromosomal
segment of unknown function (2) or the 16S rDNA (3, 33), but
their validities have been assessed with only a small number of
strains. Although 16S rDNA sequencing is accepted as a gen-
eral means for species differentiation, some heterogeneity can
exist between different isolates of the same species (14). A
recent study of the 16S rDNA sequences of several represen-
tative strains showed that R. equi is a very heterogeneous
taxon, with variations in 16S rDNAs of up to 4% (19). On the
other hand, closely related species may have identical or al-
most identical 16S rDNA sequences (6, 26). Therefore, it is
useful to have other species-specific targets, such as choE, to
undertake an assay for the reliable identification of a bacterial
species. Finally, a PCR-RFLP method targeting a 65-kDa heat
shock protein gene and primarily devised for the identification
of mycobacteria was shown to discriminate R. equi strains (42).
However, this assay is too laborious and lengthy because, due
to the conserved nature of the 65-kDa heat shock protein gene,
the amplification product is of the same size for all actinomy-
cete species and R. equi can be discriminated only by restriction
analysis of the amplicon.
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In summary, we describe a new PCR assay which can be
usefully applied for the rapid, sensitive, and reliable identifi-
cation of R. equi isolates and their differentiation from isolates
of other pathogenic and nonpathogenic actinomycetes.
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